Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans
- 1 February 1991
- journal article
- Published by Springer Nature in Psychopharmacology
- Vol. 103 (2) , 258-264
- https://doi.org/10.1007/bf02244213
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatientsJournal of Affective Disorders, 1987
- Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Ritanserin, a Serotonin-S2 Receptor Antagonist, Does Not Prevent 5-Hydroxytryptophan-Induced β-EP, β-LPH and Cortisol SecretionHormone Research, 1987
- L‐Tryptophan and prolactin release: Evidence for interaction between 5‐HT1 and 5‐HT2 receptorsHuman Psychopharmacology: Clinical and Experimental, 1986
- Endocrinological Function in Schizophrenic Patients under Haloperidol Treatment: Plasma PRL, HGH and 5HT Levels after L-5HTP LoadingPsychiatry and Clinical Neurosciences, 1985
- Prolactin Suppression by Serotonin Antagonists in Man: Further Evidence for Serotoninergic Control of Prolactin SecretionNeuroendocrinology, 1978
- Failure of Oral 5-Hydroxytryptophan Administration to Affect Prolactin Secretion in ManHormone Research, 1976
- Failure of 5-Hydroxytryptophan to Stimulate Prolactin and Growth Hormone Secretion in ManHormone and Metabolic Research, 1975
- Stimulation of Human Prolactin Secretion by Intravenous Infusion of L-TryptophanJournal of Clinical Investigation, 1973